How Ph.D. was paid
$10.9M in total for fiscal 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|---|
| Bahija Jallal, Ph.D.Chief Executive Officer | $765,000 | — | $2,819,992 | $6,579,990 | $688,500 | $31,786 | $10,885,268 |
| Travis CoyChief Financial Officer | $500,000 | $100,000 | — | $4,299,989 | $250,000 | $21,220 | $5,171,209 |
| Tina St. LegerChief Human Resources Officer | $374,946 | — | $250,890 | $376,357 | $179,974 | $23,150 | $1,204,261 |
| David Berman, M.D., Ph.D.Former Executive Vice President, Head of Research & Development | $540,000 | — | $1,399,991 | $2,099,992 | $216,000 | $23,005 | $4,278,988 |
What changed and why
- Base salaries for executive officers were held flat for fiscal year 2025.
- Restricted stock units were introduced as part of the long-term incentive plan alongside options.
- Short-term incentives incorporated a significant weighting on six specific revenue and portfolio goals.
- $12.9MCEO total compensation decreased from $12,852,234 in 2024 to $10,885,268 in 2025.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.